Fiche centre
Inselspital, Bern
Bern — Switzerland
Essais liés3clinical trials
VilleBernlocalisation
PaysSwitzerlandlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03993678
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Denosumab (reduced dosing) | Cancer | Phase 3 | NCT02051218 | Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks | TERMINATED |
| IP-001 | Cancer | Phase 1/2 | NCT03993678 | Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors. | COMPLETED |
| BIBX 1382 | Cancer | Phase 1 | NCT00003980 | BIBX 1382 in Treating Patients With Solid Tumors | SUSPENDED |